Mỹ đồng ý chi hơn 1 tỷ USD mua thuốc điều trị COVID-19 của Merck & Co

(TTXVN/Vietnam+) 08:25 10/06/2021

Ngày 9/6, hãng dược phẩm Merck & Co Inc cho biết Chính phủ Mỹ đã nhất trí chi khoảng 1,2 tỷ USD để mua 1,7 triệu liệu trình thuốc Molnupiravir đang được thử nghiệm điều trị bệnh COVID-19, nếu cuộc thử nghiệm quy mô lớn hiện nay cho thấy thuốc có tác dụng và được cơ quan quản lý dược phẩm Mỹ cấp phép.

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